Identification of sulfonylpyrimidines as novel selective aldosterone synthase (CYP11B2) inhibitors

被引：1

作者：

Meguro, Masaki ^{[1
]}

Miyauchi, Satoru ^{[2
]}

Kanao-Arisumi, Yukiko ^{[3
]}

Naito, Satoru ^{[4
]}

Suzuki, Kanae ^{[1
]}

Inoue, Shinichi ^{[5
]}

Yamada, Keisuke ^{[6
]}

Homma, Tsuyoshi ^{[1
]}

Chiba, Kiyoshi ^{[1
]}

Nara, Futoshi ^{[7
]}

Furuzono, Shinji ^{[1
]}

机构：

[1] Daiichi Sankyo Co Ltd, Shinagawa R&D Ctr, 1-2-58 Hiromachi,Shinagawa Ku, Tokyo 1408710, Japan

[2] Daiichi Sankyo Co Ltd, Technol Div, Technol Business Management Grp, 1-12-1 Shinomiya, Hiratsuka, Kanagawa 2540014, Japan

[3] Pharmaun Co Ltd, 1-23-39 Hiikawa,Jounan Ku, Fukuoka, Fukuoka 8140153, Japan

[4] Daiichi Sankyo Business Associe Co Ltd, Site Operat Dept, Shinagawa Site Operat Grp, 1-2-58 Hiromachi,Shinagawa Ku, Tokyo 1408710, Japan

[5] Daiichi Sankyo Inc, 211 Mt Airy Rd, Basking Ridge, NJ 07920 USA

[6] Daiichi Sankyo Co Ltd, Med Affairs Div, Med Affairs Planning Dept, 3-5-1 Nihonbashi Honcho,Chuo Ku, Tokyo 1038426, Japan

[7] Shin Nippon Biomed Labs Ltd, 8-1-28 Akashicho,Chuo Ku, Tokyo 1040044, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2024年 / 108卷

关键词：

Aldosterone; Aldosterone synthase inhibitor; Sulfone; Amino-pyrimidine; IN-VIVO ACTIVITY; POTENTIAL TREATMENTS; DISCOVERY; LCI699; THIOLS;

D O I：

10.1016/j.bmc.2024.117775

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

4-[(5-[2-Methyl-5-(methylsulfonyl)pentan-2-yl]sulfonylpyrimidin-4-yl)amino]benzonitrile 2 was identified as a novel potent aldosterone synthase inhibitor. Compound 2 was found to inhibit human CYP11B2 in the nanomolar range, and showed an aldosterone-lowering effect in a furosemide-treated cynomolgus monkey model. Although human CYP11B2 has the high homology sequence with human CYP11B1, compound 2 showed more than 80 times higher selectivity over human CYP11B1 in vitro.

引用

页数：15

共 50 条

[21] Two novel mutations of the CYP11B2 gene in a Japanese patient with aldosterone deficiency type 1
Kondo, Eisuke
Nakamura, Akie
Homma, Keiko
Hasegawa, Tomonobu
Yamaguchi, Takeshi
Narugami, Masahiko
Hattori, Tetsuo
Aoyagi, Hayato
Ishizu, Katsura
Tajima, Toshihiro
ENDOCRINE JOURNAL, 2013, 60 (01) : 51 - 55
[22] High aldosterone-to-renin variants of CYP11B2 and pregnancy outcome
Escher, Genevieve
Cristiano, Martino
Causevic, Maja
Baumann, Marc
Frey, Felix J.
Surbek, Daniel
Mohaupt, Markus G.
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (06) : 1870 - 1875
[23] Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction
Hautanen, A
Toivanen, P
Mänttäri, M
Tenkanen, L
Kupari, M
Manninen, V
Kayes, KM
Rosenfeld, S
White, PC
CIRCULATION, 1999, 100 (22) : 2213 - 2218
[24] Variegated distribution of CYP11B2 contributes to complex aldosterone production in aldosterone-producing adenoma
Zhang, Kaiyan
Liu, Chunxiao
Li, Wei
Wu, Zhun
Xing, Jinchun
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (04): : 7193 - 7200
[25] Inhibition Of Aldosterone Synthesis In Non-human Primates By PB6440, The Novel Highly Selective And Potent CYP11B2 Inhibitor
Pitt, Bertram
Bhatt, Deepak L.
Morris, Karen
Becherer, J. David
Hoekstra, William
Shotzinger, Robert
Sparks, Steven
Lee, John S.
HYPERTENSION, 2020, 76
[26] Immunohistochemistry for aldosterone synthase CYP11B2 and matrix-assisted laser desorption ionization imaging mass spectrometry for in-situ aldosterone detection
Zhang, Zhen
Sugiura, Yuki
Mune, Tomoatsu
Nishiyama, Mitsuru
Terada, Yoshio
Mukai, Kuniaki
Nishimoto, Koshiro
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2019, 28 (02) : 105 - 112
[27] The cytochrome 11B2 aldosterone synthase gene CYP11B2 (RS1799998) polymorphism associates with chronic kidney disease in hypertensive patients
Dzhuryak, Valentina
Sydorchuk, Larysa
Sydorchuk, Andrii
Kamyshnyi, Olexandr
Kshanovska, Anna
Levytska, Svitlana
Knut, Ruslan
Sheremet, Michael
Ivashchuk, Serhiy
Petrynych, Oksana
Kazantseva, Tetiana
Nikyfor, Livia
Melnychuk, Larysa
Sokolenko, Alina
Yarynych, Yulia
Semianiv, Marianna
Repchuk, Yulia
Voroniuk, Ksenia
Sydorchuk, Ruslan
Sokolenko, Ludmila
Iftoda, Oksana
Kushnir, Oksana
BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2020, 10 (03): : 5406 - 5411
[28] The human steroid hydroxylases CYP11B1 and CYP11B2
Bureik, M
Lisurek, M
Bernhardt, R
BIOLOGICAL CHEMISTRY, 2002, 383 (10) : 1537 - 1551
[29] In silico selectivity modeling of pyridine and pyrimidine based CYP11B1 and CYP11B2 inhibitors: A case study
Matore, Balaji Wamanrao
Banjare, Purusottam
Singh, Jagadish
Roy, Partha Pratim
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2022, 116
[30] Identification of Mineralocorticoid Receptors, Aldosterone, and Its Processing Enzyme CYP11B2 on Parasympathetic and Sympathetic Neurons in Rat Intracardiac Ganglia
Dehe, Lukas
Mousa, Shaaban A.
Aboryag, Noureddin
Shaqura, Mohammed
Beyer, Antje
Schaefer, Michael
Treskatsch, Sascha
FRONTIERS IN NEUROANATOMY, 2022, 15

← 1 2 3 4 5 →